Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy.
Sharzehi
Kaveh
K
Division of Gastroenterology and Hepatology, Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania 17033, USA. ksharzehi@hmc.psu.edu
Huang
Mary Ann
MA
Schreibman
Ian R
IR
Brown
Kimberly A
KA
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D004351:Drug Resistance; D004361:Drug Tolerance; D005260:Female; D019693:Hepatitis, Autoimmune / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012189:Retrospective Studies; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid